Key result
SEA0400 has no effect on mitochondrial Ca2+, suggesting protection stems from plasmalemmal NCX inhibition.
Why the study?
The mitochondrial effects of SEA0400, a plasmalemmal Na+/Ca2+ exchanger inhibitor that reduces mitochondrial Ca2+ overload during myocardial ischemia, were unclear.
The mitochondria-protective effects of SEA0400 are likely mediated by inhibition of plasmalemmal NCX rather than mitochondrial NCX.
Answers are grounded in this paper and cite their sources.
Prioritizes plasmalemmal NCX targets for future inhibitors; animal data leave mitochondrial contributions unresolved for clinical testing.
We investigated the effect on mitochondrial Ca2+ of SEA0400, an inhibitor of the Na+/Ca2+ exchanger (NCX) which reduces mitochondrial Ca2+ overload during myocardial ischemia, in digitonin-permeabilized H9c2 cells expressing the mitochondrial-targeted Ca2+ indicator, yellow cameleon 3.1. The elevation of mitochondrial Ca2+ concentration caused by an increase in extramitochondrial Ca2+ concentration was inhibited by carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) or ruthenium red, but enhanced by CGP-37157, a mitochondrial NCX inhibitor. SEA0400 had no effect on mitochondrial Ca2+ under normal and ischemic conditions. Thus, the mitochondria-protective effects of SEA0400 could be explained by inhibition of plasmalemmal NCX but not mitochondrial NCX.
No takes yet. Share an insight, caveat, or question.
Namekata et al. (2017) studied Myocardial ischemia (in vitro model). SEA0400 vs. Control was evaluated on Mitochondrial Ca2+ concentration (yellow cameleon fluorescence ratio). SEA0400 had no direct effect on mitochondrial Ca2+ concentration under normal or ischemic conditions, suggesting its protective effects stem from plasmalemmal rather than mitochondrial NCX inhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: